ASN95 -- Selected abstracts: Minimal Change Disease
Sun. Nov. 5 1995
4:00 P.M. ---Free Communications--- San Diego
Conv Ctr Rm 2
Therapy of
glomerular disease
Program number 730 at 5:00
Anti-interleukin 8 neutralizing
antibody abolishes proteinuria induced in vivo by supernatant factor
from minimal change patients in
relapse. E.H. Garin
and L. Chandler. - Tampa, FL.
Mon. Nov. 6 1995
9:00 A.M. ---Poster--- San Diego Conv Ctr
Halls A and B
Vascular cell
structure and signalling
Program number 1288 Board# M557 at 10:00 A.M.
The endothelial cell as a potential target for a human vasoactive
plasma factor associated with
minimal change nephrotic syndrome.
P.K. Cheung, F.W.J. Dijkhuis and W.W. Bakker. -
Groningen, The Netherlands.
4:00 P.M. ---Free Communications--- San Diego Conv Ctr Rm 3
Glomerular syndromes
Program number 1384 at 5:15
Glomerular number in focal
segmental glomerulosclerosis and minimal change nephrotic syndrome.
A. Vats, J. Basgen, M.
Steffes and M. Mauer. -
Minneapolis, MN.
Tue. Nov. 7 1995
9:00 A.M. ---Poster highlights--- San Diego
Conv Ctr Halls A and B
Glomerular diseases
Program number 1556 at na
Effect of 1-alpha(OH)D3 on steroid
induced osteoporosis in frequently relapsing childhood minimal change
nephrotic syndrome.
B-S. Cho, H-S. Yoon, C-G. Ihn,
S-H. Cha and D-Y. Kim. - Seoul, Korea.
Program number 1558 at na
Toxic oxygen products generated in
inflammatory cells by a human plasma factor involved in minimal change
disease. P.K.
Cheung, B.W.A. Van der Strate and
W.W. Bakker. - Groningen, The Netherlands.
Use BACK arrow on your browser (faster) or click
here to go back to ASN95 main page
Click
on ARROW for HDCN Home Page.